Edition:
United States

Oasmia Pharmaceutical AB (OASM.OQ)

OASM.OQ on NASDAQ Stock Exchange Capital Market

1.48USD
21 Jun 2018
Change (% chg)

-- (--)
Prev Close
$1.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,726
52-wk High
$3.10
52-wk Low
$0.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Apr '18 0.84 -0.182
Jan '18 0.66 -0.165
Oct 1.65 -0.143
Jul 0.02 -0.232
FY 2017 Apr '17 0.04 -0.345
Jan '17 0.04 -0.330
Oct 0.06 -0.377
Jul 0.04 -0.337
FY 2016 Apr '16 0.06 -0.305
Jan '16 6.04 -0.235
Oct 0.05 -0.433
Jul 0.22 -0.398
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Apr-18 1 8.00 8.00 8.00 --
Year Ending Apr-19 1 48.00 48.00 48.00 198.00
Year Ending Apr-20 1 383.00 383.00 383.00 484.00
Earnings (per share)
Year Ending Apr-18 1 -0.69 -0.69 -0.69 --
Year Ending Apr-19 1 -0.54 -0.54 -0.54 -0.48
Year Ending Apr-20 1 0.35 0.35 0.35 0.64
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.95 33.54
P/E High - Last 5 Yrs. -- 41.95 47.76
P/E Low - Last 5 Yrs. -- 23.75 25.07
Beta 0.85 0.80 0.79
Price to Sales (TTM) 248.19 3.61 8.28
Price to Book (MRQ) 2.25 3.61 4.21
Price to Tangible Book (MRQ) -- 4.64 6.00
Price to Cash Flow (TTM) -- 20.09 22.70
% Owned Institutions -- 1.29 2.44

Dividends

  Company industry sector
Dividend Yield -- 1.88 1.74
Dividend Yield - 5 Year Avg 0.00 1.51 1.43
Dividend 5 Year Growth Rate -- -9.33 -6.29
Payout Ratio(TTM) -- 43.96 41.21

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,815.91 4.42 5.43
Sales (TTM) vs TTM 1 Yr. Ago 1,743.02 10.68 12.81
Sales - 5 Yr. Growth Rate -- 7.12 7.89
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.23 45.47 40.97
EPS (TTM) vs TTM 1 Yr. Ago 48.03 -- --
EPS - 5 Yr. Growth Rate -- 6.39 8.04
Capital Spending - 5 Yr. Growth Rate -19.03 6.66 7.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.32 2.58 2.55
Current Ratio (MRQ) 0.36 3.66 3.62
LT Debt to Equity (MRQ) -- 10.75 13.20
Total Debt to Equity (MRQ) 54.27 14.90 17.68
Interest Coverage (TTM) -7.11 41.07 36.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 249.94 55.46 55.10
Gross Margin - 5 Yr. Avg. 591.85 52.87 52.98
EBITD Margin (TTM) -3,110.57 -- --
EBITD - 5 Yr. Avg -4,706.08 18.49 15.70
Operating Margin (TTM) -3,272.08 14.35 -0.37
Operating Margin - 5 Yr. Avg. -4,924.11 14.16 10.89
Pre-Tax Margin (TTM) -3,722.81 14.62 1.60
Pre-Tax Margin - 5 Yr. Avg. -5,423.88 14.38 11.06
Net Profit Margin (TTM) -3,722.81 11.23 -1.69
Net Profit Margin - 5 Yr. Avg. -5,423.88 10.72 7.42
Effective Tax Rate (TTM) -- 21.59 29.75
Effective Tax Rate - 5 Yr. Avg. -- 23.70 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 839,606,985 727,953,282
Net Income/Employee (TTM) -- 97,788,069 84,747,764
Receivable Turnover (TTM) 3.93 5.92 6.05
Inventory Turnover (TTM) -0.41 2.57 3.67
Asset Turnover (TTM) 0.01 0.90 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -21.66 10.78 10.32
Return on Assets - 5 Yr. Avg. -25.38 11.55 10.99
Return on Investment (TTM) -36.57 13.56 13.09
Return on Investment - 5 Yr. Avg. -39.72 14.99 14.27
Return on Equity (TTM) -36.57 15.37 15.10
Return on Equity - 5 Yr. Avg. -39.75 16.22 15.63
  1 Year 3 Year 5 Year
Sales % 1,742.44 15.25 --
EPS (TTM) % 48.81 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Oasmia Pharmaceutical AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.32 9.56 99 55
13 Week 12.97 9.21 99 25
26 Week 70.54 72.66 99 26
52 Week 37.50 42.60 99 16
YTD 67.94 67.14 99 24
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.73%
# of Holders: 9
Total Shares Held: 10,115,065
3 Mo. Net Change: -2,116,877
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 2
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.